Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | Ribociclib | 0.1 | 0.7180 | 0.01284 |
| HCC1143 | Ribociclib | 0.1 | 0.7670 | 0.00929 |
| HCC1143 | Ribociclib | 0.316227766017 | 0.7269 | 0.01993 |
| HCC1143 | Ribociclib | 0.316227766017 | 0.7383 | 0.00062 |
| HCC1143 | Ribociclib | 0.316227766017 | 0.7211 | -0.00117 |
| HCC1143 | Ribociclib | 1.0 | 0.7038 | -0.00051 |
| HCC1143 | Ribociclib | 1.0 | 0.6985 | 0.05952 |
| HCC1143 | Ribociclib | 1.0 | 0.7597 | -0.01064 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.6333 | -0.00033 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5129 | 0.01217 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5572 | 0.00588 |
| HCC1143 | Ribociclib | 10.0 | 0.2697 | 0.06072 |
| HCC1143 | Ribociclib | 10.0 | 0.3009 | 0.02871 |
| HCC1143 | Ribociclib | 10.0 | 0.3199 | 0.02588 |
| HCC1143 | LY3023414 | 0.001 | 0.8479 | -0.00186 |
| HCC1143 | LY3023414 | 0.001 | 0.8214 | 0.00391 |
| HCC1143 | LY3023414 | 0.001 | 0.8542 | -0.00978 |
| HCC1143 | LY3023414 | 0.00316227766017 | 0.7821 | 0.00707 |
| HCC1143 | LY3023414 | 0.00316227766017 | 0.7357 | 0.00437 |
| HCC1143 | LY3023414 | 0.00316227766017 | 0.8078 | 0.00820 |
| HCC1143 | LY3023414 | 0.01 | 0.7601 | 0.00097 |
| HCC1143 | LY3023414 | 0.01 | 0.6616 | -0.00190 |
| HCC1143 | LY3023414 | 0.01 | 0.8763 | 0.00180 |
| HCC1143 | LY3023414 | 0.0316227766017 | 0.6900 | 0.02290 |
| HCC1143 | LY3023414 | 0.0316227766017 | 0.6393 | 0.02097 |